Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 3949813, 14 pages
http://dx.doi.org/10.1155/2016/3949813
Research Article

Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis

1Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
2Department of Anatomy, School of Medicine and Institute of Health Sciences, Gyeongsang National University, Jinju 660-701, Republic of Korea
3Joan and Sanford I. Weill Department of Medicine, New York-Presbyterian Hospital, and Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, NY 10065, USA

Received 27 August 2015; Revised 24 November 2015; Accepted 30 November 2015

Academic Editor: Borna Relja

Copyright © 2016 Yingqing Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Balaban, “Regulation of oxidative phosphorylation in the mammalian cell,” The American Journal of Physiology—Cell Physiology, vol. 258, no. 3, pp. C377–C389, 1990. View at Google Scholar · View at Scopus
  2. Y. Hatefi, “The mitochondrial electron transport and oxidative phosphorylation system,” Annual Review of Biochemistry, vol. 54, pp. 1015–1069, 1985. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Wu, P. Puigserver, U. Andersson et al., “Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1,” Cell, vol. 98, no. 1, pp. 115–124, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Andersson and R. C. Scarpulla, “PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells,” Molecular and Cellular Biology, vol. 21, no. 11, pp. 3738–3749, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Escrivá, A. Rodríguez-Peña, and C. G. Vallejo, “Expression of mitochondrial genes and of the transcription factors involved in the biogenesis of mitochondria Tfam, NRF-1 and NRF-2, in rat liver, testis and brain,” Biochimie, vol. 81, no. 10, pp. 965–971, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Wei, R. S. Rector, J. P. Thyfault, and J. A. Ibdah, “Nonalcoholic fatty liver disease and mitochondrial dysfunction,” World Journal of Gastroenterology, vol. 14, no. 2, pp. 193–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Santamaría, M. A. Avila, M. U. Latasa et al., “Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 6, pp. 3065–3070, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Pérez-Carreras, P. Del Hoyo, M. A. Martín et al., “Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis,” Hepatology, vol. 38, no. 4, pp. 999–1007, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Piantadosi, M. S. Carraway, A. Babiker, and H. B. Suliman, “Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1,” Circulation Research, vol. 103, no. 11, pp. 1232–1240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Alam, D. Stewart, C. Touchard, S. Boinapally, A. M. K. Choi, and J. L. Cook, “Nrf2, a Cap‘n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene,” The Journal of Biological Chemistry, vol. 274, no. 37, pp. 26071–26078, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Joe, M. Zheng, H. J. Kim et al., “Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 309, no. 1, pp. G21–G29, 2015. View at Publisher · View at Google Scholar
  12. Y. Kimura, T. Tani, T. Kanbe, and K. Watanabe, “Effect of cilostazol on platelet aggregation and experimental thrombosis,” Arzneimittel-Forschung, vol. 35, no. 7, pp. 1144–1149, 1985. View at Google Scholar · View at Scopus
  13. C. Lugnier, “Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents,” Pharmacology and Therapeutics, vol. 109, no. 3, pp. 366–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Y. Kim, H. K. Shin, J. M. Choi, and K. W. Hong, “Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells,” The Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 2, pp. 709–715, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. S. Park, W.-K. Jung, D.-Y. Lee et al., “Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms,” International Immunopharmacology, vol. 10, no. 9, pp. 1077–1085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Saito, K. Hata, K. Iwaisako et al., “Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis,” Hepatology Research, vol. 44, no. 4, pp. 460–473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Zuo, Q. Li, B. Sun, Z. Xu, and Z. Ge, “Cilostazol promotes mitochondrial biogenesis in human umbilical vein endothelial cells through activating the expression of PGC-1α,” Biochemical and Biophysical Research Communications, vol. 433, no. 1, pp. 52–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kuzuya and F. Kuzuya, “Probucol as an antioxidant and antiatherogenic drug,” Free Radical Biology and Medicine, vol. 14, no. 1, pp. 67–77, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. G. A. A. Ferns, L. Forster, A. Stewart-Lee, J. Nourooz-Zadeh, and E. E. Änggård, “Probucol inhibits mononuclear cell adhesion to vascular endothelium in the cholesterol-fed rabbit,” Atherosclerosis, vol. 100, no. 2, pp. 171–181, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Zapolska-Downar, A. Zapolski-Downar, M. Markiewski, A. Ciechanowicz, M. Kaczmarczyk, and M. Naruszewicz, “Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-1) expression in human vascular endothelial cells,” Atherosclerosis, vol. 155, no. 1, pp. 123–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-M. Deng, B. J. Wu, P. K. Witting, and R. Stocker, “Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1,” Circulation, vol. 110, no. 13, pp. 1855–1860, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. J. Wu, K. Kathir, P. K. Witting et al., “Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging,” The Journal of Experimental Medicine, vol. 203, no. 4, pp. 1117–1127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Y. Park, J. H. Lee, C. D. Kim, B. Y. Rhim, K. W. Hong, and W. S. Lee, “Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats,” Brain Research, vol. 1157, no. 1, pp. 112–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Yoshikawa, K. Mitani, K. Kotosai, M. Nozako, G. Miyakoda, and Y. Yabuuchi, “Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet,” Hormone and Metabolic Research, vol. 40, no. 7, pp. 473–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. H. Kim, K. W. Hong, S. S. Bae, Y.-I. Shin, B. T. Choi, and H. K. Shin, “Probucol plus cilostazol attenuate hypercholesterolemia-induced exacerbation in ischemic brain injury via anti-inflammatory effects,” International Journal of Molecular Medicine, vol. 34, no. 3, pp. 687–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Timmins, L. Ozcan, T. A. Seimon et al., “Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways,” The Journal of Clinical Investigation, vol. 119, no. 10, pp. 2925–2941, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Zheng, S.-K. Kim, Y. Joe et al., “Sensing endoplasmic reticulum stress by protein kinase RNA-like endoplasmic reticulum kinase promotes adaptive mitochondrial DNA biogenesis and cell survival via heme oxygenase-1/carbon monoxide activity,” The FASEB Journal, vol. 26, no. 6, pp. 2558–2568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Tenhunen, H. S. Marver, and R. Schmid, “The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 61, no. 2, pp. 748–755, 1968. View at Publisher · View at Google Scholar · View at Scopus
  29. F. W. Booth and D. B. Thomason, “Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models,” Physiological Reviews, vol. 71, no. 2, pp. 541–585, 1991. View at Google Scholar · View at Scopus
  30. R. S. Williams, M. Garcia-Moll, J. Mellor, S. Salmons, and W. Harlan, “Adaptation of skeletal muscle to increased contractile activity. Expression nuclear genes encoding mitochondrial proteins,” The Journal of Biological Chemistry, vol. 262, no. 6, pp. 2764–2767, 1987. View at Google Scholar · View at Scopus
  31. D. C. Wallace, “Mitochondrial diseases in man and mouse,” Science, vol. 283, no. 5407, pp. 1482–1488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. S. H. Caldwell, R. H. Swerdlow, E. M. Khan et al., “Mitochondrial abnormalities in non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 31, no. 3, pp. 430–434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. Sanyal, C. Campbell-Sargent, F. Mirshahi et al., “Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities,” Gastroenterology, vol. 120, no. 5, pp. 1183–1192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Begriche, A. Igoudjil, D. Pessayre, and B. Fromenty, “Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it,” Mitochondrion, vol. 6, no. 1, pp. 1–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Oyadomari, H. P. Harding, Y. Zhang, M. Oyadomari, and D. Ron, “Dephosphorylation of translation initiation factor 2α enhances glucose tolerance and attenuates hepatosteatosis in mice,” Cell Metabolism, vol. 7, no. 6, pp. 520–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-S. Lee, R. Mendez, H. H. Heng, Z.-Q. Yang, and K. Zhang, “Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation,” American Journal of Translational Research, vol. 4, no. 1, pp. 102–113, 2012. View at Google Scholar · View at Scopus
  37. L. E. Otterbein, F. H. Bach, J. Alam et al., “Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway,” Nature Medicine, vol. 6, no. 4, pp. 422–428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Brouard, L. E. Otterbein, J. Anrather et al., “Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis,” The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1015–1026, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. K. D. Poss and S. Tonegawa, “Reduced stress defense in heme oxygenase 1-deficient cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 20, pp. 10925–10930, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Piantadosi, C. M. Withers, R. R. Bartz et al., “Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression,” The Journal of Biological Chemistry, vol. 286, no. 18, pp. 16374–16385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. B. Suliman, M. S. Carraway, L. G. Tatro, and C. A. Piantadosi, “A new activating role for CO in cardiac mitochondrial biogenesis,” Journal of Cell Science, vol. 120, no. 2, pp. 299–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Y. Park, S. W. Lee, S. H. Baek et al., “Induction of heme oxygenase-1 expression by cilostazol contributes to its anti-inflammatory effects in J774 murine macrophages,” Immunology Letters, vol. 136, no. 2, pp. 138–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. F. R. Jornayvaz and G. I. Shulman, “Regulation of mitochondrial biogenesis,” Essays in Biochemistry, vol. 47, pp. 69–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. C. A. Piantadosi and H. B. Suliman, “Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1820, no. 4, pp. 532–541, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani, “Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study,” Hepatology, vol. 42, no. 1, pp. 44–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kim, Y. Joe, S. O. Jeong et al., “Endoplasmic reticulum stress is sufficient for the induction of IL-1beta production via activation of the NF-kappaB and inflammasome pathways,” Innate Immunity, vol. 20, no. 8, pp. 799–815, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S.-H. Chang, J. Garcia, J. A. Melendez, M. S. Kilberg, and A. Agarwal, “Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain,” The Biochemical Journal, vol. 371, no. 3, pp. 877–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. St-Pierre, S. Drori, M. Uldry et al., “Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators,” Cell, vol. 127, no. 2, pp. 397–408, 2006. View at Publisher · View at Google Scholar · View at Scopus